generic competition

New drug-spending leader: Diabetes

admin — Thu, 15 May 2008 06:59:58 -0400

New data on pharma sales details some big shifts in spending. Diabetes meds have displaced cholesterol drugs as the Read more...

Generics makers face Chinese threat

admin — Wed, 14 May 2008 06:59:57 -0400

In an interesting twist on the usual generics news, it's the copycat makers who are predicted to suffer as competitors undercut their products. The source of this competition? None other than China, Read more...

GSK accused of monopolizing Wellbutrin

admin — Thu, 08 May 2008 06:59:57 -0400

Did GlaxoSmithKline try to monopolize the Wellbutrin market? A lawsuit now certified as class-action says so. The plaintiffs accuse GSK of artificially boosting Wellbutrin prices by fibbing to the Read more...

AZ stock falls on Symbicort patent loss

admin — Wed, 07 May 2008 06:59:56 -0400

What a difference one patent ruling can make. AstraZeneca lost almost $1.3 billion in market value today after announcing that the European Patent Office yanked a patent covering its blockbuster Read more...

Make generic-switching bonuses illegal?

admin — Mon, 05 May 2008 06:59:55 -0400

Should insurers be allowed to reward docs who switch patients to generics? That debate is going public in Colorado, where legislators have proposed a bill that would prohibit the practice. On the Read more...

Drugmakers resist U.K. price goals

admin — Mon, 05 May 2008 06:59:54 -0400

Drug companies are standing their ground in price negotiations with the U.K. government. Pharma is offering to cut the U.K.'s drug bill by roughly half the government's goal, The Daily Telegraph Read more...

Could Clarinex be vulnerable to generics?

admin — Wed, 30 Apr 2008 06:59:55 -0400

Consider this scenario from Fred Hassan's nightmares: The $800 million Clarinex, ostensibly under patent till 2020, Read more...

Wyeth to slash another 1,200 jobs

admin — Tue, 29 Apr 2008 06:59:58 -0400

And the ax is falling again. Wyeth notified employees last Friday than another 1,200 jobs will be slashed from the payroll. That's on top of the Read more...

Under pharma earnings, basic problems

admin — Wed, 23 Apr 2008 06:59:55 -0400

You've heard of see-through buildings. How about see-through pharma earnings? Though drug makers have been reporting increases to their bottom lines, investors are looking past the foreign-currency Read more...

Wyeth discounts Pristiq for big sales push

admin — Wed, 23 Apr 2008 06:59:54 -0400

Think the latest-and-greatest drug would naturally be the most expensive? Think again. Now that its Pristiq antidepressant is Read more...